When it comes to CLL/SLL treatment, what’s the difference between BTK inhibitors and BCL-2 inhibitors? Understanding how these treatment approaches work and how they fit into the treatment…
BTK degrader BGB-16673 reduced tumor burden in 85% of patients from a high-risk, hard-to-treat group with relapsed / refractory CLL. Dr. Stephan Stilgenbauer from Ulm University and colleagues…
New research is helping scientists better understand gene modification’s effects on many forms of bladder cancer. Additionally, results from numerous recent studies seem to foreshadow a change of…
Astronaut Scott Kelly, and his twin brother (retired astronaut) Mark, are part of an ongoing NASA study examining the differences in immune responses to influenza and other pathogens…
Each month we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
New 3d-printing technology from the research labs of Wake Forest University hopes to speed up the healing process for burn victims and patients with severe skin wounds. This…
Adult immunity to influenza is very closely tied to the strains of the virus that patients were exposed to as children. This means that older adults might have…
Over a decade ago, the Institute of Medicine of the National Academies published a report that found the annual cost of premature births in the United States exceeded…
A potential new treatment for Alzheimer's and progressive supranuclear palsy has shown an ability to help patients repair and regrow teeth by stimulating stem cells to produce large…
Instead of vaccinating patients with weakened versions of a virus, it may be possible to modify the virus so it is incapable of infecting a host, but still…
